Tracheal cytotoxin (TCT) is a soluble piece of peptidoglycan (PGN) found in the cell wall of all gram-negative bacteria, but only some bacteria species release TCT including Bordetella pertussis, Vibrio fischeri, and Neisseria gonorrhoeae

Tracheal cytotoxin (TCT) is a 921 dalton glycopeptide released by Bordetella pertussisVibrio fischeri (as a symbiosis chemical), and Neisseria gonorrhoeae (among other peptidoglycan-derived cytotoxins it produces).

It is a soluble piece of peptidoglycan (PGN) found in the cell wall of all gram-negative bacteria, but only some bacteria species release TCT due to inability to recycle this piece of anhydromuropeptide.

History

In 1980, it was discovered that B. pertussis could attach to hamster tracheal epithelial (HTE) cells, and also, that the supernatant from the cultured bacterium could disrupt the cell cycle of uninfected cells.

  • Goldman, W.E. and J.B. Baseman (March 1980). “Abstr. Ann. Meet. Am. Soc. Microbiol”. Abstr. Ann. Meet. Am. Soc. Microbiol.[page needed]

This prompted the scientists W. E. Goldman, D. G. Klapper, and J. B. Baseman to isolate and characterize a novel substance from B. pertussis supernatant. The novel disaccharide tetrapeptide that they had purified showed toxicity for HTE cells and tracheal ring cultures. Subsequently, they named the newly sequestered molecule tracheal cytotoxin (TCT).

Molecular structure of TCT

Structure

TCT is a soluble piece of peptidoglycan (PGN) found in the cell wall of all gram-negative bacteria.

Like all PGNs, TCT is composed of a disaccharide and a peptide chain. The IUPAC name for TCT is N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramyl-(L)-alanyl-γ-(D)-glutamyl-mesodiaminopimelyl-(D)-alanine.

  • Cookson, BT; Tyler, AN; Goldman, WE (1989). “Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis”. Biochemistry28 (4): 1744–9. doi:10.1021/bi00430a048PMID 2541765.
Analogs of TCT. LacAEDapA retains the peptide chain of TCT along with toxicity despite the lack of disaccharide. LacAEαApmA loses the diamino group of TCT along with a significant level of toxicity.

It is classified as a DAP (diaminopimelic acid)-type PGN due to the third amino group within the chain being a diaminopimelyl peptide.

Diaminopimelic acid (DAP) is an amino acid, representing an epsilon-carboxy derivative of lysine. DAP is a characteristic of certain cell walls[Brooks, George H.; Geo F. Brooks (2007). Jawetz, Melnick & Adelberg’s medical microbiology. McGraw-Hill Medical. pp. 85ISBN 978-0-07-147666-9.] of some bacteria. DAP is often found in the peptide linkages of NAM-NAG chains that make up the cell wall of gram-negative bacteria. When provided, they exhibit normal growth. When in deficiency, they still grow but with the inability to make new cell wall peptidoglycan. This is also the attachment point for Braun’s lipoprotein.[Seltmann, Guntram; Holst, Otto (2002). The Bacterial Cell Wall. Berlin: Springer. pp. 81–82. ISBN 3-540-42608-6.] See also Aspartate-semialdehyde dehydrogenase, an enzyme involved in DAP synthesis and Peptidoglycan and Pimelic acid.

The DAP residue is responsible for directly bonding to the D-alanine peptide of another PGN molecule, thus aiding TCT’s attachment within the cell wall.

The DAP portion of TCT also implies importance in cytopathogenicity as analogs lacking DAP show a significant reduction in toxicity.

Mechanism of pathogenesis

Most Gram-negative bacteria keep TCT within the cell wall by using a PGN-transporter protein known as AmpG. However, B. pertussis is not capable of recycling PGNs via AmpG and thus, TCT escapes into the surrounding environment.

Configuration of TCT within the cell wall of a bacterium

Also, TCT appears to be constitutively expressed[dubious – discuss] by B. pertussis.

The first murine-model studies using TCT involved treatment of hamster tracheal cells. These experiments alluded to TCT’s role in ciliostasis and cellular extrusion of ciliated hamster cells. Also, HTE cells had a markedly reduced level of DNA synthesis post-treatment with TCT.

While previous studies using murine models reported evidence of TCT causing ciliostasis, in vitro studies using human tracheal cells have shown that TCT does not affect ciliary beat frequency of living cells, but instead causes damage and eventual extrusion of ciliated cells.

  • Jacobs, C; Joris, B; Jamin, M; Klarsov, K; Van Beeumen, J; Mengin-Lecreulx, D; Van Heijenoort, J; Park, JT; et al. (1995). “AmpD, essential for both beta-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase”. Molecular Microbiology15 (3): 553–9. doi:10.1111/j.1365-2958.1995.tb02268.xPMID 7783625S2CID 40169153.

In gonorrhea infections, vaginal ciliated epithelial cells have also displayed the same cytopathogenic effects due to TCT recognition.

Illustration showing the effects of TCT on human ciliated epithelial cells. Figure A illustrates normal human epithelial tissue. Figure B illustrates normal human epithelial tissue after incubation with TCT. Notice the damaged and extruded ciliated epithelial cells in Figure B.

The extensive damage to ciliated epithelial tissue caused by TCT results in major disruption to the ciliary escalator; an important asset of the host’s non-specific defenses. This disruption hinders the host’s ability to remove mucous and foreign microbes from the epithelial tissue. Paroxysmal cough, e.g. whooping cough, is a direct symptom of said mucous build-up due to ciliated tissue damage.

NOD-1 recognition and the presence of Lipooligosaccharide (LOS) are two factors that modulate the effect of TCT. NOD-1 is a pattern recognition receptor that detects peptidoglycan. This receptor reacts weakly to TCT in humans, but robustly in mice. TCT is thought to work synergistically with LOS to mediate an inflammatory response, thus causing damage to ciliated epithelial cells.

Notably, the human pathogens (B. pertussis and N. gonorrhea) that produce excess TCT, causing damage to cilia also both produce LOS in their outer membrane.

Lipopolysaccharides are composed of three parts: The O antigen (or O polysaccharide), the Core oligosaccharide, and Lipid A. O-antigen The repetitive glycan polymer contained within an LPS is referred to as the O antigen, O polysaccharide, or O side-chain of the bacteria. The O antigen is attached to the core oligosaccharide, and comprises the outermost domain of the LPS molecule. The composition of the O chain varies from strain to strain; there are over 160 different O antigen structures produced by different E. coli strains.[Raetz CR, Whitfield C (2002). “Lipopolysaccharide endotoxins”Annu. Rev. Biochem71: 635–700. doi:10.1146/annurev.biochem.71.110601.135414PMC 2569852PMID 12045108.] The presence or absence of O chains determines whether the LPS is considered “rough” or “smooth”. Full-length O-chains would render the LPS smooth, whereas the absence or reduction of O-chains would make the LPS rough.[ Rittig MG, Kaufmann A, Robins A, Shaw B, Sprenger H, Gemsa D, Foulongne V, Rouot B, Dornand J (2003). “Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes”J. Leukoc. Biol74 (6): 1045–55. doi:10.1189/jlb.0103015PMID12960272] Bacteria with rough LPS usually have more penetrable cell membranes to hydrophobic antibiotics, since a rough LPS is more hydrophobic.[Tsujimoto H, Gotoh N, Nishino T (1999). “Diffusion of macrolide antibiotics through the outer membrane of Moraxella catarrhalis”. J. Infect. Chemother5 (4): 196–200. doi:10.1007/s101560050034PMID 11810516S2CID 2742306.] O antigen is exposed on the very outer surface of the bacterial cell, and, as a consequence, is a target for recognition by host antibodies. Core Main article: Core oligosaccharide The core domain always contains an oligosaccharide component that attaches directly to lipid A and commonly contains sugars such as heptose and 3-Deoxy-D-manno-oct-2-ulosonic acid (also known as KDO, keto-deoxyoctulosonate).[Hershberger C, Binkley SB (1968). “Chemistry and metabolism of 3-deoxy-D-mannooctulosonic acid. I. Stereochemical determination”J. Biol. Chem243 (7): 1578–84. doi:10.1016/S0021-9258(18)93581-7PMID 4296687.] The LPS cores of many bacteria also contain non-carbohydrate components, such as phosphate, amino acids, and ethanolamine substituents. Lipid A Main article: Lipid A Lipid A is, in normal circumstances, a phosphorylated glucosamine disaccharide decorated with multiple fatty acids. These hydrophobic fatty acid chains anchor the LPS into the bacterial membrane, and the rest of the LPS projects from the cell surface. The lipid A domain is responsible for much of the toxicity of Gram-negative bacteria. When bacterial cells are lysed by the immune system, fragments of membrane containing lipid A are released into the circulation, causing fever, diarrhea, and possible fatal endotoxic shock (also called septic shock). The Lipid A moiety is a very conserved component of the LPS.[Tzeng YL, Datta A, Kolli VK, Carlson RW, Stephens DS (May 2002). “Endotoxin of Neisseria meningitidis composed only of intact lipid A: inactivation of the meningococcal 3-deoxy-D-manno-octulosonic acid transferase”J. Bacteriol184 (9): 2379–88. doi:10.1128/JB.184.9.2379-2388.2002PMC 134985PMID 11948150.] However Lipid A structure varies among bacterial species. Lipid A structure largely defines the degree and nature of the overall host immune activation.[Khan, Mohd M.; Ernst, Orna; Sun, Jing; Fraser, Iain D. C.; Ernst, Robert K.; Goodlett, David R.; Nita-Lazar, Aleksandra (24 June 2018). “Mass Spectrometry-based Structural Analysis and Systems Immunoproteomics Strategies for Deciphering the Host Response to Endotoxin”. Journal of Molecular Biology430 (17): 2641–2660. doi:10.1016/j.jmb.2018.06.032ISSN 1089-8638PMID 29949751S2CID 49481716.] Lipooligosaccharides The “rough form” of Lipopolysaccharides (LPS) has a lower molecular weight due to the absence of the O polysaccharide. In its place is a short oligosaccharide: this form is known as Lipooligosaccharide (LOS), and is a glycolipid found in the outer membrane of some types of Gram-negative bacteria, such as Neisseria spp. and Haemophilus spp.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.][Kilár A, Dörnyei Á, Kocsis B (2013). “Structural characterization of bacterial lipopolysaccharides with mass spectrometry and on- and off-line separation techniques”. Mass Spectrom Rev32 (2): 90–117. Bibcode:2013MSRv…32…90Kdoi:10.1002/mas.21352PMID 23165926.] LOS plays a central role in maintaining the integrity and functionality of the outer membrane of the Gram negative cell envelope. LOS play an important role in the pathogenesis of certain bacterial infections because they are capable of acting as immunostimulators and immunomodulators.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] Furthermore, LOS molecules are responsible for the ability of some bacterial strains to display molecular mimicry and antigenic diversity, aiding in the evasion of host immune defenses and thus contributing to the virulence of these bacterial strains. In the case of Neisseria meningitidis, the lipid A portion of the molecule has a symmetrical structure and the inner core is composed of 3-deoxy-D-manno-2-octulosonic acid (KDO) and heptose (Hep) moieties. The outer core oligosaccharide chain varies depending on the bacterial strain.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.][Kilár A, Dörnyei Á, Kocsis B (2013). “Structural characterization of bacterial lipopolysaccharides with mass spectrometry and on- and off-line separation techniques”. Mass Spectrom Rev32 (2): 90–117. Bibcode:2013MSRv…32…90Kdoi:10.1002/mas.21352PMID 23165926.]…Portions of the LPS from several bacterial strains have been shown to be chemically similar to human host cell surface molecules; the ability of some bacteria to present molecules on their surface which are chemically identical or similar to the surface molecules of some types of host cells is termed molecular mimicry.[Chastain EM, Miller SD (2012). “Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease”Immunol. Rev245 (1): 227–38. doi:10.1111/j.1600-065X.2011.01076.xPMC 3586283PMID 22168423.] For example, in Neisseria meningitidis L2,3,5,7,9, the terminal tetrasaccharide portion of the oligosaccharide (lacto-N-neotetraose) is the same tetrasaccharide as that found in paragloboside, a precursor for ABH glycolipid antigens found on human erythrocytes.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] In another example, the terminal trisaccharide portion (lactotriaose) of the oligosaccharide from pathogenic Neisseria spp. LOS is also found in lactoneoseries glycosphingolipids from human cells.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] Most meningococci from groups B and C, as well as gonococci, have been shown to have this trisaccharide as part of their LOS structure.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] The presence of these human cell surface ‘mimics’ may, in addition to acting as a ‘camouflage’ from the immune system, play a role in the abolishment of immune tolerance when infecting hosts with certain human leukocyte antigen (HLA) genotypes, such as HLA-B35.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] LPS can be sensed directly by hematopoietic stem cells (HSCs) through the bonding with TLR4, causing them to proliferate in reaction to a systemic infection. This response activate the TLR4-TRIF-ROS-p38 signaling within the HSCs and through a sustained TLR4 activation can cause a proliferative stress, leading to impair their competitive repopulating ability.[Takizawa, Hitoshi; Fritsch, Kristin; Kovtonyuk, Larisa V.; Saito, Yasuyuki; Yakkala, Chakradhar; Jacobs, Kurt; Ahuja, Akshay K.; Lopes, Massimo; Hausmann, Annika (3 August 2017). “Pathogen-Induced TLR4-TRIF Innate Immune Signaling in Hematopoietic Stem Cells Promotes Proliferation but Reduces Competitive Fitness”Cell Stem Cell21 (2): 225–240.e5. doi:10.1016/j.stem.2017.06.013ISSN 1875-9777PMID 28736216] Infection in mice using S. typhimurium showed similar results, validating the experimental model also in vivo…Normal human blood serum contains anti-LOS antibodies that are bactericidal and patients that have infections caused by serotypically distinct strains possess anti-LOS antibodies that differ in their specificity compared with normal serum.[Yamasaki R, Kerwood DE, Schneider H, Quinn KP, Griffiss JM, Mandrell RE (1994). “The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide”J. Biol. Chem269 (48): 30345–51. doi:10.1016/S0021-9258(18)43819-7PMID 7982947.] These differences in humoral immune response to different LOS types can be attributed to the structure of the LOS molecule, primarily within the structure of the oligosaccharide portion of the LOS molecule.[Yamasaki R, Kerwood DE, Schneider H, Quinn KP, Griffiss JM, Mandrell RE (1994). “The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide”J. Biol. Chem269 (48): 30345–51. doi:10.1016/S0021-9258(18)43819-7PMID 7982947.] In Neisseria gonorrhoeae it has been demonstrated that the antigenicity of LOS molecules can change during an infection due to the ability of these bacteria to synthesize more than one type of LOS,[Yamasaki R, Kerwood DE, Schneider H, Quinn KP, Griffiss JM, Mandrell RE (1994). “The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide”J. Biol. Chem269 (48): 30345–51. doi:10.1016/S0021-9258(18)43819-7PMID 7982947.] a characteristic known as phase variation. Additionally, Neisseria gonorrhoeae, as well as Neisseria meningitidis and Haemophilus influenzae,[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] are capable of further modifying their LOS in vitro, for example through sialylation (modification with sialic acid residues), and as a result are able to increase their resistance to complement-mediated killing [Yamasaki R, Kerwood DE, Schneider H, Quinn KP, Griffiss JM, Mandrell RE (1994). “The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide”J. Biol. Chem269 (48): 30345–51. doi:10.1016/S0021-9258(18)43819-7PMID 7982947.] or even down-regulate complement activation[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] or evade the effects of bactericidal antibodies.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] Sialylation may also contribute to hindered neutrophil attachment and phagocytosis by immune system cells as well as a reduced oxidative burst.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] Haemophilus somnus, a pathogen of cattle, has also been shown to display LOS phase variation, a characteristic which may help in the evasion of bovine host immune defenses.[Howard MD, Cox AD, Weiser JN, Schurig GG, Inzana TJ (2000). “Antigenic diversity of Haemophilus somnus lipooligosaccharide: phase-variable accessibility of the phosphorylcholine epitope”J. Clin. Microbiol38 (12): 4412–9. doi:10.1128/JCM.38.12.4412-4419.2000PMC 87614PMID 11101573.] Taken together, these observations suggest that variations in bacterial surface molecules such as LOS can help the pathogen evade both the humoral (antibody and complement-mediated) and the cell-mediated (killing by neutrophils, for example) host immune defenses…In general the health effects of LPS are due to its abilities as a potent activator and modulator of the immune system, especially its inducement of inflammation. Endotoxemia The presence of endotoxins in the blood is called endotoxemia. High level of endotoxemia can lead to septic shock,[Opal SM (2010). “Endotoxins and other sepsis triggers”. Endotoxemia and Endotoxin ShockContrib Nephrol. Contributions to Nephrology. Vol. 167. pp. 14–24. doi:10.1159/000315915ISBN 978-3-8055-9484-4PMID 20519895.] while lower concentration of endotoxins in the bloodstream is called metabolic endotoxemia.[Gomes, Júnia Maria Geraldo; Costa, Jorge de Assis; Alfenas, Rita de Cássia Gonçalves (March 2017). “Metabolic endotoxemia and diabetes mellitus: A systematic review”Metabolism68: 133–144. doi:10.1016/j.metabol.2016.12.009PMID 28183445.] Endotoxemia is associated with obesity, diet,[Kallio, K. A. Elisa; Hätönen, Katja A.; Lehto, Markku; Salomaa, Veikko; Männistö, Satu; Pussinen, Pirkko J. (April 2015). “Endotoxemia, nutrition, and cardiometabolic disorders”Acta Diabetologica52 (2): 395–404. doi:10.1007/s00592-014-0662-3ISSN 0940-5429PMID 25326898S2CID 24020127.] cardiovascular diseases,[Kallio, K. A. Elisa; Hätönen, Katja A.; Lehto, Markku; Salomaa, Veikko; Männistö, Satu; Pussinen, Pirkko J. (April 2015). “Endotoxemia, nutrition, and cardiometabolic disorders”Acta Diabetologica52 (2): 395–404. doi:10.1007/s00592-014-0662-3ISSN 0940-5429PMID 25326898S2CID 24020127.] and diabetes,[Gomes, Júnia Maria Geraldo; Costa, Jorge de Assis; Alfenas, Rita de Cássia Gonçalves (March 2017). “Metabolic endotoxemia and diabetes mellitus: A systematic review”Metabolism68: 133–144. doi:10.1016/j.metabol.2016.12.009PMID 28183445.] while also host genetics might have an effect.[Leskelä, Jaakko; Toppila, Iiro; Härma, Mari‐Anne; Palviainen, Teemu; Salminen, Aino; Sandholm, Niina; Pietiäinen, Milla; Kopra, Elisa; Pais de Barros, Jean‐Paul; FinnGen; Lassenius, Mariann I. (20 October 2021). “Genetic Profile of Endotoxemia Reveals an Association With Thromboembolism and Stroke”Journal of the American Heart Association10 (21): e022482. doi:10.1161/JAHA.121.022482ISSN 2047-9980PMC 8751832PMID 34668383.] Moreover, endotoxemia of intestinal origin, especially, at the host-pathogen interface, is considered to be an important factor in the development of alcoholic hepatitis,[Ceccanti M, Attili A, Balducci G, Attilia F, Giacomelli S, Rotondo C, Sasso GF, Xirouchakis E, Attilia ML (2006). “Acute alcoholic hepatitis”. J. Clin. Gastroenterol40 (9): 833–41. doi:10.1097/01.mcg.0000225570.04773.5dPMID 17016141.] which is likely to develop on the basis of the small bowel bacterial overgrowth syndrome and an increased intestinal permeability.[Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C (2000). “Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease”. J. Hepatol32 (5): 742–7. doi:10.1016/S0168-8278(00)80242-1PMID 10845660.] Lipid A may cause uncontrolled activation of mammalian immune systems with production of inflammatory mediators that may lead to septic shock.[Kilár A, Dörnyei Á, Kocsis B (2013). “Structural characterization of bacterial lipopolysaccharides with mass spectrometry and on- and off-line separation techniques”. Mass Spectrom Rev32 (2): 90–117. Bibcode:2013MSRv…32…90Kdoi:10.1002/mas.21352PMID 23165926.] This inflammatory reaction is mediated by Toll-like receptor 4 which is responsible for immune system cell activation.[Kilár A, Dörnyei Á, Kocsis B (2013). “Structural characterization of bacterial lipopolysaccharides with mass spectrometry and on- and off-line separation techniques”. Mass Spectrom Rev32 (2): 90–117. Bibcode:2013MSRv…32…90Kdoi:10.1002/mas.21352PMID 23165926.] Damage to the endothelial layer of blood vessels caused by these inflammatory mediators can lead to capillary leak syndrome, dilation of blood vessels and a decrease in cardiac function and can lead to septic shock.[Stephens DS, Greenwood B, Brandtzaeg P (2007). “Epidemic meningitis, meningococcaemia, and Neisseria meningitidis”. Lancet369 (9580): 2196–210. doi:10.1016/S0140-6736(07)61016-2PMID 17604802S2CID 16951072.] Pronounced complement activation can also be observed later in the course as the bacteria multiply in the blood.[Stephens DS, Greenwood B, Brandtzaeg P (2007). “Epidemic meningitis, meningococcaemia, and Neisseria meningitidis”. Lancet369 (9580): 2196–210. doi:10.1016/S0140-6736(07)61016-2PMID 17604802S2CID 16951072.] High bacterial proliferation triggering destructive endothelial damage can also lead to disseminated intravascular coagulation (DIC) with loss of function of certain internal organs such as the kidneys, adrenal glands and lungs due to compromised blood supply. The skin can show the effects of vascular damage often coupled with depletion of coagulation factors in the form of petechiaepurpura and ecchymoses. The limbs can also be affected, sometimes with devastating consequences such as the development of gangrene, requiring subsequent amputation.[Stephens DS, Greenwood B, Brandtzaeg P (2007). “Epidemic meningitis, meningococcaemia, and Neisseria meningitidis”. Lancet369 (9580): 2196–210. doi:10.1016/S0140-6736(07)61016-2PMID 17604802S2CID 16951072.] Loss of function of the adrenal glands can cause adrenal insufficiency and additional hemorrhage into the adrenals causes Waterhouse-Friderichsen syndrome, both of which can be life-threatening. It has also been reported that gonococcal LOS can cause damage to human fallopian tubes.[Yamasaki R, Kerwood DE, Schneider H, Quinn KP, Griffiss JM, Mandrell RE (1994). “The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide”J. Biol. Chem269 (48): 30345–51. doi:10.1016/S0021-9258(18)43819-7PMID 7982947.] Auto-immune disease The molecular mimicry of some LOS molecules is thought to cause autoimmune-based host responses, such as flareups of multiple sclerosis.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.][Chastain EM, Miller SD (2012). “Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease”Immunol. Rev245 (1): 227–38. doi:10.1111/j.1600-065X.2011.01076.xPMC 3586283PMID 22168423.] Other examples of bacterial mimicry of host structures via LOS are found with the bacteria Helicobacter pylori and Campylobacter jejuni, organisms which cause gastrointestinal disease in humans, and Haemophilus ducreyi which causes chancroid. Certain C. jejuni LPS serotypes (attributed to certain tetra- and pentasaccharide moieties of the core oligosaccharide) have also been implicated with Guillain–Barré syndrome and a variant of Guillain–Barré called Miller-Fisher syndrome.[Moran AP, Prendergast MM, Appelmelk BJ (1996). “Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease”FEMS Immunol. Med. Microbiol16 (2): 105–15. doi:10.1016/s0928-8244(96)00072-7PMID 8988391.] Link to obesity Epidemiological studies have shown that increased endotoxin load, which can be a result of increased populations of endotoxin-producing bacteria in the intestinal tract, is associated with certain obesity-related patient groups.[Moreno-Navarrete JM, Ortega F, Serino M, Luche E, Waget A, Pardo G, Salvador J, Ricart W, Frühbeck G, Burcelin R, Fernández-Real JM (2012). “Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance”Int J Obes (Lond)36 (11): 1442–9. doi:10.1038/ijo.2011.256PMID 22184060.][Lepper PM, Schumann C, Triantafilou K, Rasche FM, Schuster T, Frank H, Schneider EM, Triantafilou M, von Eynatten M (2007). “Association of lipopolysaccharide-binding protein and coronary artery disease in men”J. Am. Coll. Cardiol50 (1): 25–31. doi:10.1016/j.jacc.2007.02.070PMID 17601541.][Ruiz AG, Casafont F, Crespo J, Cayón A, Mayorga M, Estebanez A, Fernadez-Escalante JC, Pons-Romero F (2007). “Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis”. Obes Surg17 (10): 1374–80. doi:10.1007/s11695-007-9243-7PMID 18000721S2CID 44494003.] Other studies have shown that purified endotoxin from Escherichia coli can induce obesity and insulin-resistance when injected into germ-free mouse models.[Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007). “Metabolic endotoxemia initiates obesity and insulin resistance”Diabetes56 (7): 1761–72. doi:10.2337/db06-1491PMID 17456850.] A more recent study has uncovered a potentially contributing role for Enterobacter cloacae B29 toward obesity and insulin resistance in a human patient.[Fei N, Zhao L (December 2012). “An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice”ISME J7 (4): 880–4. doi:10.1038/ismej.2012.153PMC 3603399PMID 23235292.] The presumed mechanism for the association of endotoxin with obesity is that endotoxin induces an inflammation-mediated pathway accounting for the observed obesity and insulin resistance.[Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007). “Metabolic endotoxemia initiates obesity and insulin resistance”Diabetes56 (7): 1761–72. doi:10.2337/db06-1491PMID 17456850.] Bacterial genera associated with endotoxin-related obesity effects include Escherichia and Enterobacter. Depression There is experimental and observational evidence that LPS might play a role in depression. Administration of LPS in mice can lead to depressive symptoms, and there seem to be elevated levels of LPS in some people with depression. Inflammation may sometimes play a role in the development of depression, and LPS is pro-inflammatory.[Lasselin, Julie; Schedlowski, Manfred; Karshikoff, Bianka; Engler, Harald; Lekander, Mats; Konsman, Jan Pieter (August 2020). “Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: Relevance for symptoms of anxiety and depression”Neuroscience and Biobehavioral Reviews115: 15–24. doi:10.1016/j.neubiorev.2020.05.001ISSN 1873-7528PMID 32433924S2CID 218665128.] Cellular senescence Inflammation induced by LPS can induce cellular senescence, as has been shown for the lung epithelial cells and microglial cells (the latter leading to neurodegeneration).[Wei W, Ji S (2018). “Cellular senescence: Molecular mechanisms and pathogenicity”. Journal of Cellular Physiology233 (12): 9121–9135. doi:10.1002/jcp.26956PMID 30078211S2CID 51924586.] Role as contaminant in biotechnology and research Lipopolysaccharides are frequent contaminants in plasmid DNA prepared from bacteria or proteins expressed from bacteria, and must be removed from the DNA or protein to avoid contaminating experiments and to avoid toxicity of products manufactured using industrial fermentation.[Wicks, Ian P.; Howell, Meredith L.; Hancock, Tuesday; Kohsaka, Hitoshi; Olee, Tsaiwei; Carson, Dennis A. (March 1995). “Bacterial Lipopolysaccharide Copurifies with Plasmid DNA: Implications for Animal Models and Human Gene Therapy”. Human Gene Therapy6 (3): 317–323. doi:10.1089/hum.1995.6.3-317PMID 7779915.] Ovalbumin is frequently contaminated with endotoxins. Ovalbumin is one of the extensively studied proteins in animal models and also an established model allergen for airway hyper-responsiveness (AHR). Commercially available ovalbumin that is contaminated with LPS can falsify research results, as it does not accurately reflect the effect of the protein antigen on animal physiology.[Watanabe, Junji; Miyazaki, Yasunari; Zimmerman, Guy A.; Albertine, Kurt H.; McIntyre, Thomas M. (24 October 2003). “Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity”The Journal of Biological Chemistry278 (43): 42361–42368. doi:10.1074/jbc.M307752200ISSN 0021-9258PMID 12909619.] In pharmaceutical production, it is necessary to remove all traces of endotoxin from drug product containers, as even small amounts of endotoxin will cause illness in humans. A depyrogenation oven is used for this purpose. Temperatures in excess of 300 °C are required to fully break down LPS.[16 December 2014. “The Detection of Endotoxins Via the LAL Test, the Chromogenic Method”. Archived from the original on 29 March 2015. Retrieved 14 March 2015.] The standard assay for detecting presence of endotoxin is the Limulus Amebocyte Lysate (LAL) assay, utilizing blood from the Horseshoe crab (Limulus polyphemus).[Iwanaga S (2007). “Biochemical principle of Limulus test for detecting bacterial endotoxins”Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci83 (4): 110–9. Bibcode:2007PJAB…83..110Idoi:10.2183/pjab.83.110PMC 3756735PMID 24019589.] 

Very low levels of LPS can cause coagulation of the limulus lysate due to a powerful amplification through an enzymatic cascade. However, due to the dwindling population of horseshoe crabs, and the fact that there are factors that interfere with the LAL assay, efforts have been made to develop alternative assays, with the most promising ones being ELISA tests using a recombinant version of a protein in the LAL assay, Factor C.[Ding JL, Ho B (2001). “A new era in pyrogen testing” (PDF). Trends Biotechnol19 (8): 277–81. doi:10.1016/s0167-7799(01)01694-8PMID 11451451. Archived from the original (PDF) on 2 January 2014. Retrieved 2 January 2014.] See also Bioaerosol and Depyrogenation and Host-pathogen interface and Mucopolysaccharide and Nesfatin-1 and Schwartzman reaction and AOAH.

Effect on immune system

TCT has been classified as an adjuvant molecule because of the stimulating effects it has on the immune system. Cellular damage associated with TCT is thought to be a result of increased levels of nitric oxide (NO) secretion by mucosal cells as part of an innate defense response to extracellular lipopolysaccharide (LPS) and TCT.

In humans, peptidoglycan recognition proteins, e.g. PGRPIαC, appear to bind with TCT and consequently induce the Tumor Necrosis Factor Receptor (TNFR) pathway.

Studies using murine macrophages have shown that TCT encourages cytokine secretion, probably through the NOD1 receptor.

As a pleiotropic toxin, TCT also acts as a pyrogen and as a stimulant of slow-wave sleep.

Pleiotropy (from Greek πλείων pleion, ‘more’, and τρόπος tropos, ‘way’) occurs when one gene influences two or more seemingly unrelated phenotypic traits. Such a gene that exhibits multiple phenotypic expression is called a pleiotropic gene. Mutation in a pleiotropic gene may have an effect on several traits simultaneously, due to the gene coding for a product used by a myriad of cells or different targets that have the same signaling function. Pleiotropy can arise from several distinct but potentially overlapping mechanisms, such as gene pleiotropy, developmental pleiotropy, and selectional pleiotropy. Gene pleiotropy occurs when a gene product interacts with multiple other proteins or catalyzes multiple reactions. Developmental pleiotropy occurs when mutations have multiple effects on the resulting phenotype. Selectional pleiotropy occurs when the resulting phenotype has many effects on fitness (depending on factors such as age and gender).[Paaby, Annalise B.; Rockman, Matthew V. (2016-11-15). “The many faces of pleiotropy”Trends in Genetics29 (2): 66–73. doi:10.1016/j.tig.2012.10.010PMC 3558540PMID 23140989.] An example of pleiotropy is phenylketonuria,  an inherited disorder that affects the level of phenylalanine, an amino acid that can be obtained from food (this ‘inherited’ disorder can be acquired and has been induced through feeding). “Phenylketonuria”Genes and Disease. National Center for Biotechnology Information. 1998.] That page goes on to discuss albinism, autism, schizophrenia, sickle cell anemia, marfun syndrome, mini-muscle allele, dna repair proteins and chickens In pharmacologypleiotropy includes all of a drug’s actions other than those for which the agent was specifically developed. It may include adverse effects which are detrimental ones,[Davignon J (June 2004). “Beneficial cardiovascular pleiotropic effects of statins”Circulation109 (23 Suppl 1): III39–43. doi:10.1161/01.CIR.0000131517.20177.5aPMID 15198965.] but is often used to denote additional beneficial effects.[Rod Flower; Humphrey P. Rang; Maureen M. Dale; Ritter, James M. (2007). Rang & Dale’s pharmacology. Edinburgh: Churchill Livingstone. ISBN 978-0-443-06911-6.] Steroid drugs, such as prednisone and prednisolone, have pleiotropic effects, including systemic ones, for the same reason that endogenous steroid hormones do: cells throughout the body have receptors that can respond to them, because the endogenous ones are endocrine messengers.

Peptidoglycan recognition protein 4 (PGLYRP4), in mammals (mice), interacts with TCT and reduces damage from pertussis inflammation. This molecule has similar immune-eliciting properties in Drosophila, where a pair of PGRPs perform the recognition.

PGLYRP4 (formerly PGRP-Iβ), a member of a family of human Peptidoglycan Recognition Proteins (PGRPs), was discovered in 2001 by Roman Dziarski and coworkers who cloned and identified the genes for three human PGRPs, PGRP-L, PGRP-Iα, and PGRP-Iβ (named for long and intermediate size transcripts),[Liu C, Xu Z, Gupta D, Dziarski R (September 2001). “Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules”The Journal of Biological Chemistry276 (37): 34686–94. doi:10.1074/jbc.M105566200PMID 11461926S2CID 44619852.] and established that human genome codes for a family of 4 PGRPs: PGRP-S (short PGRP or PGRP-S) [Kang D, Liu G, Lundström A, Gelius E, Steiner H (August 1998). “A peptidoglycan recognition protein in innate immunity conserved from insects to humans”Proceedings of the National Academy of Sciences of the United States of America95 (17): 10078–82. Bibcode:1998PNAS…9510078Kdoi:10.1073/pnas.95.17.10078PMC 21464PMID 9707603.] and PGRP-L, PGRP-Iα, and PGRP-Iβ.[Liu C, Xu Z, Gupta D, Dziarski R (September 2001). “Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules”The Journal of Biological Chemistry276 (37): 34686–94. doi:10.1074/jbc.M105566200PMID 11461926S2CID 44619852.] Subsequently, the Human Genome Organization Gene Nomenclature Committee changed the gene symbols of PGRP-S, PGRP-L, PGRP-Iα, and PGRP-Iβ to PGLYRP1 (peptidoglycan recognition protein 1), PGLYRP2 (peptidoglycan recognition protein 2), PGLYRP3 (peptidoglycan recognition protein 3), and PGLYRP4 (peptidoglycan recognition protein 4), respectively, and this nomenclature is currently also used for other mammalian PGRPs.

References

  1. Cundell, DR; Kanthakumar, K; Taylor, GW; Goldman, WE; Flak, T; Cole, PJ; Wilson, R (1994). “Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro”Infection and Immunity62 (2): 639–43. doi:10.1128/iai.62.2.639-643.1994PMC 186151PMID 8300220.
  2. Koropatnick, TA; Engle, JT; Apicella, MA; Stabb, EV; Goldman, WE; McFall-Ngai, MJ (12 November 2004). “Microbial factor-mediated development in a host-bacterial mutualism”. Science306 (5699): 1186–8. Bibcode:2004Sci…306.1186Kdoi:10.1126/science.1102218PMID 15539604S2CID 41603462Here, we report that Vibrio fischeri also releases TCT, which acts in synergy with lipopolysaccharide (LPS) to trigger tissue development in its mutualistic symbiosis with the squid Euprymna scolopes.
  3. Cloud, KA; Dillard, JP (June 2002). “A lytic transglycosylase of Neisseria gonorrhoeae is involved in peptidoglycan-derived cytotoxin production”Infection and Immunity70 (6): 2752–7. doi:10.1128/IAI.70.6.2752-2757.2002PMC 127960PMID 12010959A major peptidoglycan fragment released by gonococci is identical to the tracheal cytotoxin of Bordetella pertussis and has been shown to kill ciliated fallopian tube cells in organ culture.
  4. Mattoo, S.; Cherry, J. D. (2005). “Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies”Clinical Microbiology Reviews18 (2): 326–82. doi:10.1128/CMR.18.2.326-382.2005PMC 1082800PMID 15831828.
  5. Parkhill, Julian; Sebaihia, Mohammed; Preston, Andrew; Murphy, Lee D; Thomson, Nicholas; Harris, David E; Holden, Matthew T G; Churcher, Carol M; et al. (2003). “Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica”Nature Genetics35 (1): 32–40. doi:10.1038/ng1227PMID 12910271.
  6. Goldman, W.E. and J.B. Baseman (March 1980). “Abstr. Ann. Meet. Am. Soc. Microbiol”. Abstr. Ann. Meet. Am. Soc. Microbiol.[page needed]
  7. Goldman, William E.; Klapper, David G.; Baseman, Joel B. (1982-05-01). “Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells”Infection and Immunity36 (2): 782–94. doi:10.1128/iai.36.2.782-794.1982PMC 351298PMID 6177637.
  8. Cookson, BT; Tyler, AN; Goldman, WE (1989). “Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis”. Biochemistry28 (4): 1744–9. doi:10.1021/bi00430a048PMID 2541765.
  9. Wilson, R; Read, R; Thomas, M; Rutman, A; Harrison, K; Lund, V; Cookson, B; Goldman, W; et al. (1991-01-01). “Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro”Infection and Immunity59 (1): 337–45. doi:10.1128/iai.59.1.337-345.1991PMC 257746PMID 1987048.
  10. Luker, K. E.; Collier, J. L.; Kolodziej, E. W.; Marshall, G. R.; Goldman, W. E. (1993). “Bordetella pertussis Tracheal Cytotoxin and Other Muramyl Peptides: Distinct Structure-Activity Relationships for Respiratory Epithelial Cytopathology”Proceedings of the National Academy of Sciences90 (6): 2365–2369. Bibcode:1993PNAS…90.2365Ldoi:10.1073/pnas.90.6.2365PMC 46087PMID 8460147.
  11. Jacobs, C; Joris, B; Jamin, M; Klarsov, K; Van Beeumen, J; Mengin-Lecreulx, D; Van Heijenoort, J; Park, JT; et al. (1995). “AmpD, essential for both beta-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase”. Molecular Microbiology15 (3): 553–9. doi:10.1111/j.1365-2958.1995.tb02268.xPMID 7783625S2CID 40169153.
  12. Wilson, R; Read, R; Thomas, M; Rutman, A; Harrison, K; Lund, V; Cookson, B; Goldman, W; et al. (1991). “Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro”Infection and Immunity59 (1): 337–45. doi:10.1128/iai.59.1.337-345.1991PMC 257746PMID 1987048.
  13. Swaminathan, C. P.; Brown, P. H.; Roychowdhury, A.; Wang, Q.; Guan, R.; Silverman, N.; Goldman, W. E.; Boons, G.-J.; Mariuzza, R. A. (2006). “Dual strategies for peptidoglycan discrimination by peptidoglycan recognition proteins (PGRPs)”Proceedings of the National Academy of Sciences103 (3): 684–9. Bibcode:2006PNAS..103..684Sdoi:10.1073/pnas.0507656103PMC 1334652PMID 16407132.
  14. Melvin, Jeffrey A.; Scheller, Erich V.; Miller, Jeff F.; Cotter, Peggy A. (2014-04-01). “Bordetella pertussis pathogenesis: current and future challenges”Nature Reviews Microbiology12 (4): 274–288. doi:10.1038/nrmicro3235ISSN 1740-1526PMC 4205565PMID 24608338.
  15. Coote, JG (2001). Environmental sensing mechanisms in Bordetella. Advances in Microbial Physiology. Vol. 44. pp. 141–81. doi:10.1016/S0065-2911(01)44013-6ISBN 9780120277445PMID 11407112.
  16. Swaminathan, C. P.; Brown, PH; Roychowdhury, A; Wang, Q; Guan, R; Silverman, N; Goldman, WE; Boons, GJ; Mariuzza, RA (2006). “Dual strategies for peptidoglycan discrimination by peptidoglycan recognition proteins (PGRPs)”Proceedings of the National Academy of Sciences103 (3): 684–9. Bibcode:2006PNAS..103..684Sdoi:10.1073/pnas.0507656103PMC 1334652PMID 16407132.
  17. Humann, Jessica; Lenz, Laurel L. (2009). “Bacterial Peptidoglycan-Degrading Enzymes and Their Impact on Host Muropeptide Detection”Journal of Innate Immunity1 (2): 88–97. doi:10.1159/000181181PMC 2659621PMID 19319201.
  18. Magalhaes, Joao Gamelas; Philpott, Dana J; Nahori, Marie-Anne; Jéhanno, Muguette; Fritz, Joerg; Bourhis, Lionel Le; Viala, Jérôme; Hugot, Jean-Pierre; et al. (2005). “Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin”EMBO Reports6 (12): 1201–7. doi:10.1038/sj.embor.7400552PMC 1369207PMID 16211083.
  19. Skerry, C; Goldman, WE; Carbonetti, NH (February 2019). “Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to Bordetella pertussis and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation”Infection and Immunity87 (2). doi:10.1128/IAI.00601-18PMC 6346131PMID 30510103.
  20. Chang, CI; Chelliah, Y; Borek, D; Mengin-Lecreulx, D; Deisenhofer, J (24 March 2006). “Structure of tracheal cytotoxin in complex with a heterodimeric pattern-recognition receptor”. Science311 (5768): 1761–4. Bibcode:2006Sci…311.1761Cdoi:10.1126/science.1123056PMID 16556841S2CID 25416989.

External links

Categories

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.